Examines neonatal factors and gut microbiota in newborns with elevated CRP levels, suggesting important implications for health.
AIM: Plasma C-reactive protein (CRP) is widely used to assess neonatal infection, although mild, unexplained elevations are common in healthy newborns. We examined relationships between non-infectious CRP levels and neonatal factors, and early gut microbiota composition in term infants. METHODS: This study was conducted within the prospective Finnish HELMi birth cohort. We included 105 full-term infants with plasma CRP levels measured during the first four postnatal days. Perinatal data were retrieved from medical records. Faecal samples collected at 3 weeks underwent 16S rRNA gene sequencing. RESULTS: Initial CRP level was elevated (≥ 3 mg/L) in 57% of infants, with no diagnosis of an infection. CRP levels were not associated with maternal group B Streptococcus status, intrapartum antibiotics, early neonatal complications or delivery mode, except for higher levels on day three after spontaneous versus induced vaginal delivery. Gut microbiota composition at 3 weeks differed according to CRP status, with family Acidaminococcaceae being less prevalent when CRP was elevated. Birth mode, antibiotic exposure and umbilical artery pH in the asphyxia range (≤ 7.1) were associated with distinct microbial profiles. CONCLUSIONS: Mild CRP elevations in term newborns were associated with differences in early gut microbiota composition but poorly explained by perinatal clinical factors.
No takes yet. Share an insight, caveat, or question.
Gardemeister et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: